Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Stockholders Equity Over TimeStrong
Percentile Rank100
3Y CAGR+32.5%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
+32.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$1.13B+9.3%
2024$1.03B+123.3%
2023$463.44M-4.6%
2022$485.81M-10.5%
2021$542.94M+363.2%
2020$-206.29M-66.0%
2019$-124.27M-